Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation

An essential regulator of gene transcription, nuclear receptor liver receptor homologue 1 (LRH-1) controls cell differentiation in the developing pancreas and maintains cholesterol homeostasis in adults. Recent genome-wide association studies linked mutations in the LRH-1 gene and its up-stream regulatory regions to development of pancreatic cancer. In this work, we show that LRH-1 transcription is activated up to 30-fold in human pancreatic cancer cells compared to normal pancreatic ductal epithelium. This activation correlates with markedly increased LRH-1 protein expression in human pancreatic ductal adenocarcinomas in vivo. Selective blocking of LRH-1 by receptor specific siRNA significantly inhibits pancreatic cancer cell proliferation in vitro. The inhibition is tracked in part to the attenuation of the receptor’s transcriptional targets controlling cell growth, proliferation, and differentiation. Previously, LRH-1 was shown to contribute to formation of intestinal tumors. This study demonstrates the critical involvement of LRH-1 in development and progression of pancreatic cancer, suggesting the LRH-1 receptor as a plausible therapeutic target for treatment of pancreatic ductal adenocarcinomas.

[1]  A. Menssen,et al.  Characterization of the c-MYC-regulated transcriptome by SAGE: Identification and analysis of c-MYC target genes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  E. Musgrove,et al.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer , 2010, Cell Division.

[3]  Richard J Whitby,et al.  Small molecule agonists of the orphan nuclear receptors steroidogenic factor-1 (SF-1, NR5A1) and liver receptor homologue-1 (LRH-1, NR5A2). , 2011, Journal of medicinal chemistry.

[4]  Luzhe Sun,et al.  Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. , 2010, Cancer research.

[5]  G. Cox,et al.  Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. , 1995, Journal of immunology.

[6]  Gerald C. Chu,et al.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.

[7]  S. Reed,et al.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle. , 2000, Current opinion in cell biology.

[8]  H. Ingraham,et al.  The DEAD-Box Protein DP103 (Ddx20 or Gemin-3) Represses Orphan Nuclear Receptor Activity via SUMO Modification , 2005, Molecular and Cellular Biology.

[9]  Janet Hager,et al.  Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP , 2005, Nature Structural &Molecular Biology.

[10]  J. Auwerx,et al.  Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Clarke,et al.  Identification of pancreatic cancer stem cells. , 2007, Cancer research.

[12]  A. Cooney,et al.  Canonical Wnt/β-Catenin Regulation of Liver Receptor Homolog-1 Mediates Pluripotency Gene Expression , 2010, Stem cells.

[13]  M. McMahon,et al.  Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines , 2005, Genes, chromosomes & cancer.

[14]  J. Kench,et al.  Stabilization of beta-catenin induces pancreas tumor formation. , 2008, Gastroenterology.

[15]  M. Hebrok,et al.  It's a free for all--insulin-positive cells join the group of potential progenitors for pancreatic ductal adenocarcinoma. , 2009, Cancer cell.

[16]  T. Golub,et al.  Impaired microRNA processing enhances cellular transformation and tumorigenesis , 2007, Nature Genetics.

[17]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[18]  W. Rainey,et al.  Liver receptor homolog-1 regulates the expression of steroidogenic acute regulatory protein in human granulosa cells. , 2004, The Journal of clinical endocrinology and metabolism.

[19]  Yuriy L Orlov,et al.  The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. , 2010, Cell stem cell.

[20]  T. Willson,et al.  Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1 , 2005, Cell.

[21]  Scott A. Busby,et al.  A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects , 2011, Nature.

[22]  S. Kliewer,et al.  Orphan Nuclear Receptor LRH-1 Is Required To Maintain Oct4 Expression at the Epiblast Stage of Embryonic Development , 2005, Molecular and Cellular Biology.

[23]  S. McColl,et al.  Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha , 1992, The Journal of experimental medicine.

[24]  J. Kench,et al.  Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma , 2007, PloS one.

[25]  C. Chelala,et al.  Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays , 2008, Oncogene.

[26]  Johan Auwerx,et al.  LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. , 2004, Trends in cell biology.

[27]  R. Fletterick,et al.  The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 , 2008, Proceedings of the National Academy of Sciences.

[28]  D. Stacey.  Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells. , 2003, Current opinion in cell biology.

[29]  E. Hahn,et al.  The Expression Pattern of PDX-1, SHH, Patched and Gli-1 Is Associated with Pathological and Clinical Features in Human Pancreatic Cancer , 2008, Pancreatology.

[30]  P. Delerive,et al.  Interleukin-1 Receptor Antagonist Induction as an Additional Mechanism for Liver Receptor Homolog-1 to Negatively Regulate the Hepatic Acute Phase Response* , 2007, Journal of Biological Chemistry.

[31]  D. Moore,et al.  Phosphorylation of the Hinge Domain of the Nuclear Hormone Receptor LRH-1 Stimulates Transactivation* , 2006, Journal of Biological Chemistry.

[32]  M. Hebrok,et al.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. , 2010, The Journal of clinical investigation.

[33]  Evan R. Simpson,et al.  Regulation of aromatase expression by the nuclear receptor LRH-1 in adipose tissue , 2004, Molecular and Cellular Endocrinology.

[34]  T. Maudelonde,et al.  The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene , 2005, Oncogene.

[35]  B. Chung,et al.  Zebrafish ftz-f1a (nuclear receptor 5a2) functions in skeletal muscle organization. , 2005, Developmental biology.

[36]  Y. Wang,et al.  Prospero-related homeobox (Prox1) is a corepressor of human liver receptor homolog-1 and suppresses the transcription of the cholesterol 7-alpha-hydroxylase gene. , 2004, Molecular endocrinology.

[37]  J. Auwerx,et al.  Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. , 2004, Molecular cell.

[38]  Gregory Y. Lauwers,et al.  Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.

[39]  Johan Auwerx,et al.  Liver Receptor Homolog 1 Controls the Expression of Carboxyl Ester Lipase* , 2003, Journal of Biological Chemistry.

[40]  J. Auwerx,et al.  Pancreatic-Duodenal Homeobox 1 Regulates Expression of Liver Receptor Homolog 1 during Pancreas Development , 2003, Molecular and Cellular Biology.

[41]  B. O’Malley,et al.  Maturation of microRNA is hormonally regulated by a nuclear receptor. , 2009, Molecular cell.

[42]  J. Gustafsson,et al.  Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[44]  W. Lichtenegger,et al.  Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer. , 2008, Cytokine.

[45]  Wei Zheng,et al.  A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33 , 2010, Nature Genetics.

[46]  T. Brunner,et al.  The nuclear receptor LRH-1 critically regulates extra-adrenal glucocorticoid synthesis in the intestine , 2006, The Journal of experimental medicine.